Skip to content

JANSEN - CEUPPENS: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

JANSEN - CEUPPENS

BE 0436.608.282
NACE 47.730, Retail sale of pharmaceutical products
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€496,622
2024 · €293,410+€203,212
Equity
€2.6m
2024 · €2.3m+€371,622
Cash
€234,672
2024 · €159,553+€75,119
Balance sheet total
€2.9m
2024 · €2.5m+€382,898

Largest movements

2024 to 2025
Assets
  • Current investments +€308,026

    up €308,026 (+25.6%), from €1.2m to €1.5m

  • Cash +€75,119

    up €75,119 (+47.1%), from €159,553 to €234,672

    mainly Net result for the year (+€496,622) and Receivables within one year (+€25,241)

Equity and liabilities
  • Profit (loss) carried forward +€371,622

    up €371,622 (+21.1%), from €1.8m to €2.1m

Income statement
  • Financial income +€181,193

    up €181,193 (+2,877%), from €6,298 to €187,491

    of which Non-recurring financial income: +€145,043

  • Gross operating margin +€63,561

    up €63,561 (+12.1%), from €524,061 to €587,622

  • Taxes +€22,429

    up €22,429 (+43.1%), from €51,990 to €74,419

  • Staff costs +€17,324

    up €17,324 (+10.3%), from €168,574 to €185,898

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €293,410
Gross operating margin +€63,561
Staff costs -€17,324
Depreciation -€2,092
Other operating charges -€8
Other operating items +€1,259
Financial income +€181,193
Financial charges -€946
Taxes -€22,429
Result 2025 €496,622
raises the resultlowers the resultnot broken down further in the accounts

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€526,298
Investment -€326,179
Financing -€125,000
Cash 2024 €159,553
Net result for the year +€496,622
Depreciation +€11,809
Stocks and contracts -€18,288
Receivables within one year +€25,241
Smaller working-capital items -€958
Trade debts +€24,638
Tax, wage and social debts -€2,970
Other debts -€9,796
Investment in fixed assets (net) -€18,153
Current investments -€308,026
Contributions, distributions and other -€125,000
Cash 2025 €234,672
brings cash intakes cash out
Every line side by side 51 lines
Line Code 2024 2025 Change %
Total assets 20/58 €2,522,476 €2,905,374 +€382,898 +15.2%
Fixed assets 21/28 €37,343 €43,687 +€6,344 +17.0%
Intangible fixed assets 21 - €10,830 +€10,830
Tangible fixed assets 22/27 €32,234 €27,748 -€4,486 -13.9%
Land and buildings 22 €7,153 €4,842 -€2,311 -32.3%
Plant, machinery and equipment 23 €11,377 €10,328 -€1,049 -9.2%
Furniture and vehicles 24 €1,108 €548 -€560 -50.6%
Other tangible fixed assets 26 €12,596 €12,030 -€566 -4.5%
Financial fixed assets 28 €5,109 €5,109 = 0.0%
Current assets 29/58 €2,485,133 €2,861,686 +€376,553 +15.2%
Stocks and contracts in progress 3 €386,069 €404,357 +€18,288 +4.7%
Stocks 30/36 €386,069 €404,357 +€18,288 +4.7%
Amounts receivable within one year 40/41 €733,338 €708,097 -€25,241 -3.4%
Trade receivables 40 €92,903 €99,116 +€6,212 +6.7%
Other amounts receivable 41 €640,435 €608,982 -€31,453 -4.9%
Current investments 50/53 €1,201,912 €1,509,938 +€308,026 +25.6%
Cash at bank and in hand 54/58 €159,553 €234,672 +€75,119 +47.1%
Deferred charges and accrued income 490/1 €4,261 €4,622 +€361 +8.5%
Total equity and liabilities 10/49 €2,522,476 €2,905,374 +€382,898 +15.2%
Equity 10/15 €2,256,612 €2,628,235 +€371,622 +16.5%
Contributions 10/11 €74,370 €74,370 = 0.0%
Reserves 13 €420,766 €420,766 = 0.0%
Non-distributable reserves 130/1 €7,437 €7,437 = 0.0%
Reserves not available under the articles 1311 €7,437 €7,437 = 0.0%
Distributable reserves 133 €413,329 €413,329 = 0.0%
Profit (loss) carried forward 14 €1,761,477 €2,133,099 +€371,622 +21.1%
Amounts payable 17/49 €265,863 €277,139 +€11,276 +4.2%
Amounts payable within one year 42/48 €265,105 €276,977 +€11,872 +4.5%
Trade debts 44 €90,002 €114,640 +€24,638 +27.4%
Suppliers 440/4 €90,002 €114,640 +€24,638 +27.4%
Taxes, remuneration and social security 45 €36,417 €33,447 -€2,970 -8.2%
Taxes 450/3 €7,215 €656 -€6,559 -90.9%
Remuneration and social security 454/9 €29,201 €32,791 +€3,589 +12.3%
Other amounts payable 47/48 €138,687 €128,890 -€9,796 -7.1%
Accrued charges and deferred income 492/3 €759 €162 -€596 -78.6%
Non-recurring operating income 76A €1,277 - -€1,277
Remuneration, social security and pensions 62 €168,574 €185,898 +€17,324 +10.3%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €9,717 €11,809 +€2,092 +21.5%
Other operating charges 640/8 €1,037 €1,045 +€8 +0.7%
Non-recurring operating charges 66A €1,259 - -€1,259
Gross operating margin 9900 €524,061 €587,622 +€63,561 +12.1%
Operating profit (loss) 9901 €343,474 €388,869 +€45,396 +13.2%
Financial income 75/76B €6,298 €187,491 +€181,193 +2,877%
Recurring financial income 75 €6,143 €42,293 +€36,150 +588%
Non-recurring financial income 76B €155 €145,198 +€145,043 +93,630%
Financial charges 65/66B €4,373 €5,319 +€946 +21.6%
Recurring financial charges 65 €4,373 €5,319 +€946 +21.6%
Profit (loss) for the period before taxes 9903 €345,399 €571,041 +€225,642 +65.3%
Income taxes 67/77 €51,990 €74,419 +€22,429 +43.1%
Profit (loss) for the period 9904 €293,410 €496,622 +€203,212 +69.3%
Profit (loss) for the period to be appropriated 9905 €293,410 €496,622 +€203,212 +69.3%

Source: filed annual accounts (NBB), financial years ended 31 March 2024 and 31 March 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 31 October 2026 via checked.be.